HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Andrzej Januszewicz Selected Research
Andrzej Januszewicz Research Topics
Disease
34
Hypertension (High Blood Pressure)
01/2022 - 01/2005
24
Paraganglioma (Paragangliomas)
01/2022 - 01/2004
16
Pheochromocytoma
01/2022 - 05/2002
14
Neoplasms (Cancer)
01/2022 - 08/2006
6
Hyperaldosteronism (Conn Syndrome)
10/2020 - 01/2013
4
Essential Hypertension
01/2020 - 01/2003
4
Renal Artery Obstruction (Renal Artery Stenosis)
01/2016 - 06/2003
4
Type 2 Diabetes Mellitus (MODY)
12/2014 - 02/2006
3
Heart Failure
01/2021 - 01/2013
3
Obstructive Sleep Apnea
01/2021 - 10/2011
3
Pathologic Constriction (Stenosis)
01/2021 - 12/2017
3
Adenoma (Adenomas)
01/2020 - 01/2013
3
Coronary Artery Disease (Coronary Atherosclerosis)
01/2017 - 06/2003
3
Multiple Endocrine Neoplasia Type 2a (MEN 2)
05/2014 - 05/2002
2
Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 06/2003
2
Isolated Systolic Hypertension
12/2016 - 01/2011
2
Renal Insufficiency (Renal Failure)
01/2016 - 01/2012
2
Albuminuria
02/2015 - 02/2006
2
Sleep Apnea Syndromes (Sleep Apnea)
01/2013 - 10/2011
2
Glucose Intolerance
01/2013 - 10/2011
2
von Hippel-Lindau Disease (von Hippel Lindau Disease)
01/2010 - 05/2002
1
Neoplasm Metastasis (Metastasis)
01/2022
1
Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
01/2022
1
Multiple Myeloma
01/2021
1
Amyloidosis
01/2021
1
Hypertrophy
12/2020
1
Atrial Fibrillation
09/2020
1
Vascular Remodeling
01/2020
1
Hyperlipidemias (Hyperlipidemia)
01/2019
1
Obesity
01/2019
1
Weight Gain
01/2019
1
Body Weight (Weight, Body)
01/2019
1
Hypoxia (Hypoxemia)
04/2017
1
Cardiomegaly (Heart Hypertrophy)
01/2017
1
Papilledema
01/2016
1
Hemorrhage
01/2016
1
Hyperplasia
01/2016
1
Malignant Hypertension
01/2016
1
Chronic Kidney Failure (Chronic Renal Failure)
01/2016
1
Mood Disorders (Mood Disorder)
01/2016
Drug/Important Bio-Agent (IBA)
15
Catecholamines
IBA
01/2022 - 12/2006
12
Antihypertensive Agents (Antihypertensives)
IBA
01/2021 - 01/2003
9
Succinate Dehydrogenase (Fumarate Reductase)
IBA
01/2021 - 05/2002
8
Normetanephrine
IBA
01/2022 - 03/2013
8
Metanephrine
IBA
12/2020 - 03/2013
5
3-methoxytyramine (methoxytyramine)
IBA
01/2022 - 01/2014
5
Glucose (Dextrose)
FDA Link
Generic
01/2021 - 10/2011
4
Aldosterone
IBA
01/2022 - 11/2004
4
Angiotensin Receptor Antagonists
IBA
01/2021 - 02/2006
4
Hormones (Hormone)
IBA
01/2019 - 08/2006
3
Adrenergic Agents (Adrenergic Drugs)
IBA
01/2022 - 04/2017
3
Sodium
IBA
01/2021 - 01/2011
3
Mineralocorticoid Receptor Antagonists
IBA
10/2020 - 01/2015
3
Steroids
IBA
01/2020 - 05/2014
3
Dopamine (Intropin)
FDA Link
Generic
08/2017 - 03/2013
2
Enzymes
IBA
01/2021 - 09/2016
2
Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)
IBA
01/2021 - 01/2017
2
Retinaldehyde (Retinal)
IBA
01/2020 - 01/2016
2
Renin
IBA
01/2020 - 01/2014
2
Calcium
IBA
01/2017 - 01/2013
2
Hydrochlorothiazide (Esidrix)
FDA Link
Generic
01/2016 - 01/2007
2
Cystatin C
IBA
02/2015 - 01/2010
2
Angiotensins
IBA
01/2014 - 11/2012
2
olmesartan
IBA
04/2012 - 03/2011
2
DNA (Deoxyribonucleic Acid)
IBA
01/2010 - 01/2010
2
Olmesartan Medoxomil (Votum)
FDA Link
02/2006 - 01/2003
1
lipoprotein cholesterol
IBA
01/2022
1
Fibrin
IBA
01/2022
1
Dihydrotachysterol (AT 10)
IBA
01/2022
1
Pharmaceutical Preparations
IBA
01/2021
1
Epoprostenol (Prostacyclin)
FDA Link
Generic
01/2021
1
Neprilysin (Neutral Endopeptidase)
IBA
01/2021
1
finerenone
IBA
01/2021
1
Spironolactone (Aldactone)
FDA Link
Generic
01/2021
1
Angiotensin Receptors (Angiotensin II Receptor)
IBA
01/2021
1
4- chloro- 3',6'- dimethyl- 2,2'- iminodibenzoate (TO 115)
IBA
12/2020
1
Glucocorticoids
IBA
01/2020
1
Corticosterone
IBA
01/2020
1
Cortodoxone (11 Deoxycortisol)
IBA
01/2020
1
Hydrocortisone (Cortisol)
FDA Link
Generic
01/2020
1
Epinephrine (Adrenaline)
FDA Link
Generic
01/2019
1
Contraceptive Agents (Contraceptives)
IBA
01/2019
1
Phosphotransferases (Kinase)
IBA
04/2017
1
Salts
IBA
01/2017
1
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
01/2017
1
Angiotensin II Type 1 Receptor Blockers
IBA
01/2017
1
Drug Combinations
IBA
01/2017
1
Diuretics
IBA
12/2016
1
Hydralazine (Apresoline)
FDA Link
Generic
01/2016
1
mahuang-tang
IBA
01/2016
1
Calcitonin (Calcitonin, Eel)
FDA Link
Generic
04/2015
Therapy/Procedure
13
Therapeutics
10/2021 - 12/2005
8
Denervation
01/2021 - 10/2011
6
Catheters
01/2021 - 01/2011
5
Adrenalectomy
10/2020 - 05/2014
4
Sympathectomy (Sympathectomies)
01/2021 - 01/2011
3
Drug Therapy (Chemotherapy)
01/2017 - 12/2006
2
Radiotherapy
01/2013 - 12/2006
1
Stem Cell Transplantation
01/2021
1
Renal Dialysis (Hemodialysis)
01/2021